NCT01034982View on ClinicalTrials.gov

AZD9668 Relative Bioavailability

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

AZD9668

20 mg

DRUG

AZD9668

60 mg

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY